NUS

+ Watchlist + Portfolio

Nu Skin Enterprises, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $4.79
52-Week Range: $4.49 – $14.62
Market Cap: $226.35M
P/E (TTM): —
EPS (TTM): -4.53
Dividend Yield: 5.01%

Advanced Metrics

Price/Book: 0.28
PEG Ratio: 0.78
Return on Equity: -32.53%
Return on Assets: 3.43%
Gross Margin: 69.19%
Operating Margin: 6.11%
Profit Margin: -15.73%
Current Ratio: 1.98
Debt/Equity: 0.53
Total Debt: $288.10M
Free Cash Flow: $35.20M
Revenue Growth: -17.10%
Earnings Growth: —
Enterprise Value: $329.87M

NUS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.23B	$1.97B	$1.73B	$1.49B
Cost of Revenue	$630.91M	$611.85M	$550.23M	$453.76M
Gross Profit	$1.59B	$1.36B	$1.18B	$1.03B
Selling, General & Admin	$1.44B	$1.29B	$1.13B	$940.52M
Operating Expenses	$1.44B	$1.29B	$1.13B	$940.52M
Operating Income	$159.34M	$68.06M	$50.77M	$90.88M
EBITDA	$174.97M	$123.06M	-$78.83M	$262.41M
Pretax Income	$88.97M	$26.58M	-$175.05M	$196.20M
Income Tax	-$15.81M	$17.98M	-$28.46M	$35.99M
Net Income	$104.78M	$8.60M	-$146.59M	$160.20M
Diluted EPS	2.07	0.17	-2.95	3.18
Diluted Shares	50.52M	49.86M	49.66M	50.30M

NUS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$264.73M	$256.06M	$186.88M	$238.63M
Receivables	$47.36M	$58.70M	$50.78M	$39.54M
Inventory	$346.18M	$279.98M	$190.24M	$178.64M
Current Assets	$759.87M	$701.87M	$538.60M	$547.70M
Total Assets	$1.82B	$1.81B	$1.47B	$1.41B
Current Liabilities	$359.24M	$328.87M	$296.61M	$263.73M
Long-Term Debt	$377.47M	$478.04M	$363.61M	$204.19M
Total Debt	$520.52M	$607.33M	$478.23M	$306.61M
Total Liabilities	$923.67M	$986.66M	$817.46M	$600.07M
Retained Earnings	$1.94B	$1.87B	$1.71B	$1.86B
Shareholders' Equity	$897.30M	$821.97M	$651.46M	$805.24M
Working Capital	$400.63M	$373.00M	$241.99M	$283.96M
Net Debt	$137.74M	$246.98M	$206.73M	—

NUS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$108.06M	$118.64M	$111.74M	$80.29M
Capital Expenditure	-$59.06M	-$58.49M	-$41.58M	-$34.28M
Free Cash Flow	$49.01M	$60.15M	$70.16M	$46.01M
Depreciation & Amortisation	$72.51M	$70.92M	$69.81M	$52.26M
Stock-Based Compensation	$12.37M	$15.65M	$14.82M	$24.11M
Investing Cash Flow	-$67.08M	-$134.50M	-$37.96M	$170.66M
Financing Cash Flow	-$99.50M	$10.73M	-$133.18M	-$202.40M
Dividends Paid	-$77.02M	-$77.62M	-$11.93M	-$11.83M
Share Repurchases	-$70.05M	-$13.01M	$0.00	-$20.04M
Net Change in Cash	-$58.52M	-$5.13M	-$59.40M	$48.54M

NUS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$364.49M	$386.14M	$364.21M	$370.32M	$320.61M
Cost of Revenue	$117.53M	$120.41M	$107.49M	$108.34M	$106.14M
Gross Profit	$246.96M	$265.73M	$256.72M	$261.98M	$214.46M
Selling, General & Admin	$231.75M	$234.95M	$235.08M	$238.74M	$208.60M
Operating Expenses	$231.75M	$234.95M	$235.08M	$238.74M	$208.60M
Operating Income	$15.21M	$30.78M	$21.64M	$23.24M	$5.87M
EBITDA	$152.09M	$42.99M	$32.23M	$35.10M	$19.19M
Pretax Income	$134.60M	$27.41M	$15.99M	$18.19M	$2.60M
Income Tax	$27.09M	$6.29M	-$1.08M	$3.70M	$763.00K
Net Income	$107.52M	$21.12M	$17.08M	$14.49M	$1.84M
Diluted EPS	2.14	0.43	0.34	0.29	0.04
Diluted Shares	50.33M	49.50M	50.31M	49.91M	49.42M

NUS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$203.77M	$264.16M	$251.79M	$238.63M	$198.65M
Receivables	$56.58M	$59.70M	$48.89M	$39.54M	$45.01M
Inventory	$188.78M	$180.38M	$178.53M	$178.64M	$178.60M
Current Assets	$524.86M	$571.55M	$548.14M	$547.70M	$522.89M
Total Assets	$1.39B	$1.44B	$1.42B	$1.41B	$1.38B
Current Liabilities	$260.30M	$283.91M	$254.44M	$263.73M	$257.00M
Long-Term Debt	$218.76M	$213.90M	$209.04M	$204.19M	$203.59M
Total Debt	$300.71M	$310.74M	$291.43M	$306.61M	$277.61M
Total Liabilities	$637.44M	$655.94M	$624.61M	$600.07M	$582.71M
Retained Earnings	$1.82B	$1.83B	$1.85B	$1.86B	$1.86B
Shareholders' Equity	$753.97M	$787.75M	$799.79M	$805.24M	$794.09M
Working Capital	$264.56M	$287.65M	$293.71M	$283.96M	$265.89M
Net Debt	$34.99M	—	—	—	$24.94M

NUS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$389.00K	$35.80M	$27.48M	$16.62M	-$3.92M
Capital Expenditure	-$13.58M	-$18.00K	-$9.91M	-$10.76M	-$13.71M
Free Cash Flow	-$13.20M	$35.78M	$17.57M	$5.86M	-$17.63M
Depreciation & Amortisation	$14.21M	$13.05M	$12.09M	$12.91M	$12.34M
Stock-Based Compensation	$9.31M	$5.82M	$5.82M	$3.16M	$3.69M
Investing Cash Flow	$181.54M	$8.79M	-$9.91M	-$9.76M	-$14.29M
Financing Cash Flow	-$166.29M	$9.27M	-$26.88M	-$18.50M	-$20.40M
Dividends Paid	-$3.00M	-$2.96M	-$2.96M	-$2.91M	-$2.87M
Share Repurchases	-$5.01M	$0.00	-$5.01M	-$10.02M	-$5.01M
Net Change in Cash	$15.64M	$53.86M	-$9.31M	-$11.64M	-$38.60M

Market Snapshot

About

Nu Skin Enterprises, Inc. develops and distributes beauty, wellness, and personal care products through a direct selling model. The company operates globally with product lines including skincare, nutritional supplements, and anti-aging devices.